Cargando…
Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain – an in vivo study
Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neurodevelopmental disorder. The norepinephrine transporter (NET) inhibitor atomoxetine, the first nonstimulant drug licensed for ADHD treatment, also acts as an N-methyl-D-aspartate receptor (NMDAR) antagonist. The com...
Autores principales: | Udvardi, Patrick T, Föhr, Karl J, Henes, Carolin, Liebau, Stefan, Dreyhaupt, Jens, Boeckers, Tobias M, Ludolph, Andrea G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857115/ https://www.ncbi.nlm.nih.gov/pubmed/24348020 http://dx.doi.org/10.2147/DDDT.S50448 |
Ejemplares similares
-
Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner
por: Föhr, Karl Josef, et al.
Publicado: (2021) -
Dextroamphetamine (but Not Atomoxetine) Induces Reanimation from General Anesthesia: Implications for the Roles of Dopamine and Norepinephrine in Active Emergence
por: Kenny, Jonathan D., et al.
Publicado: (2015) -
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021) -
Cellular Zinc Homeostasis Contributes to Neuronal Differentiation in Human Induced Pluripotent Stem Cells
por: Pfaender, Stefanie, et al.
Publicado: (2016) -
Structure Modeling of the Norepinephrine Transporter
por: Góral, Izabella, et al.
Publicado: (2020)